The analyses and visuals on this site are for informational purposes only and do not constitute investment advice.

© 2026 Datafin Financial Data Analysis Systems. All rights reserved. · v2.0

Privacy PolicyTerms of UseCookie Policy

BTAI FINANCIAL STATEMENTS

BioXcel Therapeutics Inc — balance sheet, income statement and cash flow trends

BTAIBioXcel Therapeutics Inc

🇺🇸 USA · NASDAQ · Healthcare · Drug Manufacturers - Specialty & Generic

Value itDuel
PriceFinancialsPeers

Income Statement

Quarterly progression — trailing-twelve-month values
RevenueNet Income to Owners
-200 M-100 M0202120222023202420252026

Profit Funnel

Q2 2026 · TTM
Revenue742 K $Gross Profit336 K $ · 45%Operating Income-44.6 M $ · -6014%Pre-tax Income-70.9 M $ · -9550%Net Income to Owners-70.9 M $ · -9550%

Percentages are relative to revenue.

Key Figures

YoY change
Revenue742 K $-14.5%
Gross Profit336 K $—
Operating Income-44.6 M $—
EBITDA-52.8 M $—
Net Income to Owners-70.9 M $—

No peer data is available for this stock.

Balance Sheet

Quarterly period-end values
Total AssetsTotal LiabilitiesEquity
0200 M202120222023202420252026

Capital Structure

Q2 2026
Total Assets28.8 M
  • Current Liabilities137.1 M $95%
  • Long-term Liabilities7.1 M $5%

Key Figures

YoY change
Total Assets28.8 M $+11.7%
Total Liabilities144.3 M $+8.1%
Total Equity-115.5 M $—
Cash & ST Investments12.8 M $-26.3%
Total Debt104.5 M $-4.1%
Net Debt91.6 M $+0.1%

No peer data is available for this stock.

Cash Flow Statement

Quarterly progression — trailing-twelve-month values
Operating Cash FlowCapital ExpendituresFree Cash Flow
-150 M-100 M-50 M0202120222023202420252026

Cash Flow Bridge

Q2 2026 · TTM
-40 M-20 M0-50.9 M $Operating46.1 M $Financing-4.8 M $Net Change

Key Figures

YoY change
Operating Cash Flow-50.9 M $—
Capital Expenditures0 $—
Free Cash Flow-50.9 M $—
Dividends Paid——

No peer data is available for this stock.

Amounts are in the company’s reporting currency. Peer comparison tables use ratio-based metrics so currency differences do not distort the picture.

Go deeper on BTAI

Run a DCF valuation

Full DCF model with editable assumptions

Start a head-to-head duel

Compare two stocks metric by metric

Filter in the stock screener

Build your own universe with 400+ metrics

Data on this page refreshes once per day. Price data as of Sep 2, 26. This content is for informational purposes only and is not investment advice.